NCT05472649View on ClinicalTrials.gov

Long-Term Follow-Up of Patients Who Received Gene-Modified Cell Therapy

Enrolling by invitationOBSERVATIONAL
Enrollment

1

Participants

Timeline

Start Date

June 16, 2021

Primary Completion Date

December 31, 2036

Study Completion Date

May 31, 2037

Conditions
Long-term Follow-up
Interventions
BIOLOGICAL

Gene-Modified Cell Therapy

No investigational cell product will be administered

Trial Locations (1)

19104

Abramson Cancer Center Clinical Research Unit, University of Pennsylvania, Philadelphia

All Listed Sponsors
lead

Sorrento Therapeutics, Inc.

INDUSTRY